NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.590
+0.100 (6.71%)
At close: Apr 1, 2026, 4:00 PM EDT
1.600
+0.010 (0.63%)
After-hours: Apr 1, 2026, 5:05 PM EDT
NovaBay Pharmaceuticals Employees
As of December 31, 2025, NovaBay Pharmaceuticals had 4 total employees, including 2 full-time and 2 part-time employees. The number of employees decreased by 10 or -71.43% compared to the previous year.
Employees
4
Change (1Y)
-10
Growth (1Y)
-71.43%
Revenue / Employee
n/a
Profits / Employee
-$5,535,250
Market Cap
42.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | -10 | -71.43% | 2 | 2 |
| Dec 31, 2024 | 14 | -12 | -46.15% | 13 | 1 |
| Dec 31, 2023 | 26 | -7 | -21.21% | 24 | 2 |
| Dec 31, 2022 | 33 | 2 | 6.45% | 29 | 4 |
| Dec 31, 2021 | 31 | 6 | 24.00% | 29 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| NextCure | 40 |
| Werewolf Therapeutics | 39 |
| Atara Biotherapeutics | 38 |
| Palatin Technologies | 29 |
| Plus Therapeutics | 28 |
| Atossa Therapeutics | 15 |
| Rallybio | 14 |
NBY News
- 8 days ago - NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19% - Benzinga
- 9 days ago - NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - GlobeNewsWire
- 5 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 6 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 7 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 8 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 1 year ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 1 year ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire